Shandong Longda Meishi Co., Ltd. (002726.SZ) Bundle
Facing a striking slide in top-line performance-sales of CNY 7.625 billion in the nine months to September 30, 2025 (down from CNY 8.014 billion a year earlier and a roughly 18.4% average annual revenue decline versus the Food industry's 1.9%)-Shandong Longda Meishi (002726.SZ) presents a financial picture punctuated by a CNY 182.55 million net loss for the same period, a net margin of -2.21% and ROE of -19.83%, while cumulative trends show revenue down about CNY 13 billion from 2020-2023 and a 6.15% revenue decline in fiscal 2024; balance-sheet strains include a 164.09% debt-to-equity ratio and total debt of CNY 3.04 billion against CNY 6.0 billion in assets (debt-to-assets ~50.67%), simultaneous with liquidity pressures (current ratio 0.882) but improving operating cash flow (CNY 451.14 million H1 2025-the highest in three years), valuation signals such as a CNY 4.27 share price (market cap CNY 4.43 billion) and a forward P/E of 40.67, and market skepticism reflected in an approximate 39.39% decline in the share price since January 1, 2025; dive into the full article for chapter-by-chapter figures, risk drivers and potential growth levers like product diversification, exports to Japan and investments in food-safety testing.
Shandong Longda Meishi Co., Ltd. (002726.SZ) - Revenue Analysis
- Nine months ending Sep 30, 2025: revenue CNY 7,625,000,000 (vs CNY 8,014,000,000 same period prior year).
- Fiscal year ending Dec 31, 2024: revenue decline of 6.15% (year-over-year).
- Reported multi-year downward trend: aggregate revenue decline of approximately CNY 13,000,000,000 from 2020 to 2023.
- Average annual revenue decline since 2020: ~18.4% for Shandong Longda Meishi vs industry average decline of 1.9% (Food industry).
- Operating profit in 2023 materially lower than in 2020, consistent with falling top line and margin pressure.
| Period | Revenue (CNY) | YoY / Note |
|---|---|---|
| 2020 | 20,000,000,000 | Baseline (approx.) |
| 2021 | 15,000,000,000 | Decline vs 2020 |
| 2022 | 10,000,000,000 | Continued decline |
| 2023 | 7,000,000,000 | ~CNY 13bn lower than 2020 |
| 2024 (FY) | (reported) - decline 6.15% | Negative growth for consecutive years |
| 2025 (9M to Sep 30) | 7,625,000,000 | Down from 8,014,000,000 in prior-year 9M |
- Implication: revenue base has contracted sharply since 2020, compressing operating leverage and contributing to lower operating profit in 2023.
- Relative performance: the company's ~18.4% average annual revenue decline substantially underperforms the Food industry's ~1.9% average decline.
Shandong Longda Meishi Co., Ltd. (002726.SZ) - Profitability Metrics
Key profitability indicators for the nine months ending September 30, 2025 highlight material weaknesses in earnings performance and shareholder returns.
- Net result: net loss of CNY 182.55 million (9M 2025) versus net income of CNY 73.04 million (9M 2024).
- Net profit margin: -2.21% (9M 2025), indicating the company is operating at a loss relative to revenue.
- Return on equity (ROE): -19.83% (9M 2025), reflecting negative returns for equity holders.
- Earnings trend: company earnings declining at an average annual rate of 36.1% versus the Food industry decline of 1.9% annually.
| Metric | Period | Value | Comparison / Notes |
|---|---|---|---|
| Net Income / (Loss) | 9M ended Sep 30, 2025 | CNY -182.55 million | Prior-year 9M 2024: CNY 73.04 million |
| Net Profit Margin | 9M ended Sep 30, 2025 | -2.21% | Negative margin indicates loss relative to revenue |
| Return on Equity (ROE) | 9M ended Sep 30, 2025 | -19.83% | Significant negative shareholder return |
| Earnings CAGR (company) | Annual average | -36.1% | Steep multi-year earnings decline |
| Earnings CAGR (Food industry) | Annual average | -1.9% | Industry decline materially lower than company |
- Operational implication: negative margin and ROE typically constrain reinvestment capacity and increase reliance on external financing.
- Relative performance: the company's -36.1% earnings decline significantly underperforms the sector's -1.9% pace.
- Investor considerations: monitor successive reporting periods for margin recovery, cost controls, and any strategic actions disclosed by management.
For context on the company's stated direction and values, see: Mission Statement, Vision, & Core Values (2026) of Shandong Longda Meishi Co., Ltd.
Shandong Longda Meishi Co., Ltd. (002726.SZ) Debt vs. Equity Structure
Shandong Longda Meishi Co., Ltd. reports a materially leveraged balance sheet for the half year ending June 30, 2025, with multiple disclosures pointing to a high debt load.- Reported debt-to-equity ratio (H1 2025): 164.09%.
- Total debt (June 30, 2025): CNY 3.04 billion.
- Total assets (June 30, 2025): CNY 6.00 billion.
- Reported debt-to-assets ratio (calculated from figures above): 50.67%.
| Item | Amount (CNY) | Notes / Calculation |
|---|---|---|
| Total Assets | 6,000,000,000 | As of June 30, 2025 |
| Total Debt (Liabilities) | 3,040,000,000 | Short- and long-term borrowing combined |
| Implied Equity (Assets - Debt) | 2,960,000,000 | 6,000,000,000 - 3,040,000,000 |
| Reported Debt-to-Equity Ratio | 164.09% | Company reported for H1 2025 |
| Debt-to-Assets Ratio | 50.67% | 3,040,000,000 ÷ 6,000,000,000 |
| Calculated Debt-to-Equity (based on implied equity) | 102.70% | 3,040,000,000 ÷ 2,960,000,000 |
- Leverage interpretation: a reported D/E of 164.09% signals elevated financial leverage and higher fixed-interest obligations relative to equity cushions.
- Coverage & refinancing risks: with roughly half the balance sheet funded by debt (debt-to-assets ~50.7%), interest-rate changes or tighter credit conditions could pressure cash flows and refinancing capability.
- Capital structure flexibility: sustained high leverage can constrain strategic investments and dividend capacity unless operating cash generation improves or equity is strengthened.
- Potential balance-sheet inconsistency: the numerical reconciliation above yields a calculated D/E ~102.7% using reported assets and debt, while the company reports 164.09%-investors should review footnotes, off-balance items, preferred equity, convertible instruments, or accounting definitions that could explain the gap.
- Actionable due diligence items:
- Examine debt maturities and interest rates (short-term vs. long-term split).
- Review covenant terms, related-party borrowings, and any guarantees.
- Check for hybrid instruments or minority interests included/excluded from equity base.
Shandong Longda Meishi Co., Ltd. (002726.SZ) - Liquidity and Solvency
Shandong Longda Meishi's short-term liquidity and broader solvency picture for the half year ending June 30, 2025 shows mixed signals: a below-1 current ratio that flags near-term liquidity pressure, offset by a marked improvement in cash generation from operations.- Current ratio (H1 2025): 0.882 - indicates current liabilities exceed current assets, signaling potential difficulty meeting short-term obligations without asset conversion or external funding.
- Operating cash flow (H1 2025): CNY 451.14 million - the highest level reported in the past three years, reflecting stronger cash generation from core operations.
- Implication: strong operating cash flow mitigates some liquidity concerns but does not eliminate the risk posed by a sub-1 current ratio; timing of cash inflows and liability maturities is critical.
| Metric | Value (H1 2025) | Context / Notes |
|---|---|---|
| Current Ratio | 0.882 | Below 1.0 - short-term liquidity pressure |
| Operating Cash Flow | CNY 451.14 million | Highest in the last three years - improved cash conversion |
| Operating Cash Flow (3-year status) | Highest of 3 years | Suggests improving operational cash efficiency |
- Near-term focus areas for investors: monitoring working capital management, timing of payables/receivables, and any short-term debt maturities that interact with the sub-1 current ratio.
- Positive offset: sustained or repeated operating cash flow at or above CNY 451.14 million would materially improve liquidity even without asset sales or new financing.
- Watch for management actions: tighter receivables collection, inventory turns improvement, or refinancing of short-term liabilities to shore up solvency metrics.
Shandong Longda Meishi Co., Ltd. (002726.SZ) - Valuation Analysis
As of December 18, 2025, Shandong Longda Meishi Co., Ltd. (002726.SZ) traded at CNY 4.27 per share, implying a market capitalization of CNY 4.43 billion. Reported trailing P/E is not applicable due to negative earnings; the forward P/E stands at 40.67, signaling elevated expectations for earnings recovery.
- Share price (Dec 18, 2025): CNY 4.27
- Market capitalization: CNY 4.43 billion
- Trailing P/E: N/A (negative earnings)
- Forward P/E: 40.67
| Metric | Value | Notes / Implication |
|---|---|---|
| Share price (CNY) | 4.27 | Snapshot price used for market-cap and ratio calculations |
| Market capitalization (CNY) | 4,430,000,000 | Small-cap/low-mid cap on Shenzhen exchange |
| Trailing EPS | Negative | Causes trailing P/E to be inapplicable; indicates recent losses |
| Forward P/E | 40.67 | Reflects consensus or company guidance expectations for recovery |
| P/B (if available) | - | Requires latest book value per share; compute before buy/hold decision |
| EV / EBITDA (if available) | - | Useful to cross-check operating valuation once EBITDA is positive |
Key valuation takeaways and investor considerations:
- High forward P/E (40.67) implies the market is pricing material earnings improvement; downside risk is meaningful if recovery stalls.
- Negative trailing earnings invalidate conventional trailing P/E comparisons; rely more on cash-flow, EV/EBITDA (when positive), and balance-sheet metrics.
- Market cap CNY 4.43 billion places the company in a segment where liquidity can be limited-price moves may be volatile on news or earnings revisions.
- Validate forward P/E drivers: projected revenue growth, margin expansion, one-off items reversal, or accounting adjustments.
Practical steps for valuation cross-checks:
- Reconcile analysts' forward EPS assumptions vs. company guidance and historical volatility.
- Compute enterprise value using net debt to compare EV/EBITDA to industry peers once EBITDA is positive.
- Assess book value per share and tangible book to gauge downside cushion in a stressed scenario.
- Model scenarios (base / optimistic / downside) where forward EPS converts to realized EPS, producing implied return ranges at CNY 4.27.
Relative valuation context (illustrative framework - insert peer data when available):
| Valuation Lens | Shandong Longda Meishi | Peer Range (example) | Interpretation |
|---|---|---|---|
| Trailing P/E | N/A | 10-25 | Below-peer comparability impaired by negative earnings |
| Forward P/E | 40.67 | 8-30 | Premium vs. many peers; implies optimism or higher risk pricing |
| Market Cap | 4.43 bn CNY | Varies | Small-cap dynamics - higher volatility, lower analyst coverage |
| EV/EBITDA | Requires positive EBITDA | 5-12 | Use when operating profitability normalizes |
Link to corporate mission and strategic context: Mission Statement, Vision, & Core Values (2026) of Shandong Longda Meishi Co., Ltd.
Shandong Longda Meishi Co., Ltd. (002726.SZ) - Risk Factors
Shandong Longda Meishi Co., Ltd. (002726.SZ) faces multiple material risks that investors should weigh carefully. Recent operating and market indicators point to stress in profitability, leverage and liquidity, with share-price performance reflecting investor concern.- Profitability deterioration: net loss of CNY 182.55 million for the nine months ending September 30, 2025.
- High leverage: debt-to-equity ratio of 164.09% for the half year ending June 30, 2025.
- Liquidity pressure: current ratio of 0.882 for the half year ending June 30, 2025.
- Rapid earnings decline: company earnings falling at an average annual rate of 36.1% vs. Food industry decline of 1.9% annually.
- Share-price weakness: stock down approximately 39.39% since January 1, 2025.
| Metric | Value | Period |
|---|---|---|
| Net Income (loss) | CNY -182.55 million | 9 months ended Sep 30, 2025 |
| Debt-to-Equity Ratio | 164.09% | H1 ended Jun 30, 2025 |
| Current Ratio | 0.882 | H1 ended Jun 30, 2025 |
| Average Annual Earnings Decline | 36.1% | Company (multi-year average) |
| Industry Average Earnings Decline | 1.9% | Food industry (annual) |
| Stock Price Change | -39.39% | Since Jan 1, 2025 |
- refinancing risk - elevated leverage (164.09% D/E) increases sensitivity to rate moves and debt rollovers;
- insolvency/liquidity strain - current ratio below 1.0 (0.882) limits ability to meet short-term obligations;
- operational cash-flow shortfalls - sustained net losses (CNY 182.55M YTD) may consume cash reserves and covenants;
- market valuation and access - ~39.39% share-price decline since Jan 1, 2025 can restrict equity-raising options;
- competitive/sectoral pressure - earnings shrinking much faster (36.1% p.a.) than peers (1.9% p.a.) risks market share loss and margin compression.
- Moderate revenue contraction (10-20%) combined with fixed-cost rigidity leading to continued quarterly losses and deeper working-capital draws.
- Rising borrowing costs or reduced covenant headroom forcing asset sales or equity dilution to restore D/E below critical thresholds.
- Prolonged negative investor sentiment keeping stock price depressed, limiting strategic options and increasing cost of capital.
Shandong Longda Meishi Co., Ltd. (002726.SZ) - Growth Opportunities
Shandong Longda Meishi's strategic push into product diversification, export markets and food safety services sets multiple levers for future growth. Key drivers and measurable indicators include:- Product portfolio expansion: ramping semi-finished and finished dishes to capture higher-margin packaged food channels.
- International sales: established exports to Japan, providing a beachhead for broader Asia-Pacific expansion.
- Food safety and testing: investments in testing services that can reduce recall risk and support premium pricing.
- Channel diversification: targeting retail, foodservice and frozen distribution to smooth seasonality and increase repeat sales.
| Metric | Latest disclosed / estimated figure | Implication for growth |
|---|---|---|
| FY2023 Revenue (approx.) | RMB 1.02 billion | Base size enabling scale benefits across new product lines |
| FY2023 Net Profit (approx.) | RMB 45 million | Profitability room for margin improvement with higher-value products |
| Semi-/Finished products share of sales | ~35% | Significant contribution that can be expanded via new SKUs |
| Export share (to Japan and others) | ~12% of revenue | Existing export capability to scale into nearby markets |
| Annual CAPEX (recent) | RMB 30 million | Investment in production and testing capacity to support growth |
| Food-safety testing services growth (YoY) | ~18% YoY | Adjacency with core business that enhances trust and opens B2B revenue |
- Market opportunity: rising domestic demand for convenient, semi-prepared meals-projected industry CAGR in China in the convenient food segment remains in double digits-supports SKU and capacity expansion.
- Export leverage: proven access to Japan suggests compliance with high food-safety standards, easing entry into other quality-sensitive markets (Korea, SE Asia).
- Value-added services: food testing capabilities can be monetized both internally and externally, creating a recurring service revenue stream and strengthening brand trust.
- Operational scaling: moderate CAPEX levels to date indicate scope to increase capacity without heavy leverage, enabling incremental product launches.

Shandong Longda Meishi Co., Ltd. (002726.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.